Association of antitachycardia pacing or shocks with survival in 69,000 patients with an implantable defibrillator
SA Strickberger, R Canby, J Cooper… - Journal of …, 2017 - Wiley Online Library
ATP and Mortality in 69,000 ICD Patients Aims Antitachycardia pacing (ATP) is an effective
treatment for ventricular tachycardia (VT) and can reduce the frequency of shocks in patients …
treatment for ventricular tachycardia (VT) and can reduce the frequency of shocks in patients …
Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients
T Kleemann, M Strauss, K Kouraki, R Zahn - EP Europace, 2015 - academic.oup.com
Aims In patients with an implantable cardioverter-defibrillator (ICD), ICD shocks due to
ventricular tachycardia (VT) or ventricular fibrillation (VF) have been associated with an …
ventricular tachycardia (VT) or ventricular fibrillation (VF) have been associated with an …
Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients
MO Sweeney, L Sherfesee, PJ DeGroot, MS Wathen… - Heart rhythm, 2010 - Elsevier
BACKGROUND: Implantable cardioverter-defibrillator (ICD) shocks have been associated
with an increased risk of death. It is unknown whether this is due to the ventricular …
with an increased risk of death. It is unknown whether this is due to the ventricular …
Impact of accelerated ventricular tachyarrhythmias on mortality in patients with implantable cardioverter-defibrillator therapy
C Schukro, L Leitner, J Siebermair, T Pezawas… - International journal of …, 2013 - Elsevier
Background Anti-tachycardia pacing (ATP) and shock delivery may induce or accelerate
tachyarrhythmias in patients with implantable cardioverter-defibrillator (ICD). We …
tachyarrhythmias in patients with implantable cardioverter-defibrillator (ICD). We …
[HTML][HTML] Antitachycardia pacing success in implantable cardioverter-defibrillators by patient, device, and programming characteristics
LD Sterns, A Auricchio, EJ Schloss, D Lexcen… - Heart Rhythm, 2023 - Elsevier
Background Antitachycardia pacing (ATP) is an established implantable cardioverter-
defibrillator (ICD) therapy that terminates ventricular tachycardias (VTs) without painful ICD …
defibrillator (ICD) therapy that terminates ventricular tachycardias (VTs) without painful ICD …
Programming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: results from the PROVE trial
M Saeed, CG Neason, M Razavi… - Journal of …, 2010 - Wiley Online Library
Programming ATP for ICD Patients. Objectives: The PROVE trial was designed to determine
if antitachycardia pacing (ATP) is clinically beneficial for primary prevention in patients who …
if antitachycardia pacing (ATP) is clinically beneficial for primary prevention in patients who …
The association between ICD interventions and mortality is independent of their modality: clinical implications
G Bencardino, A Di Monaco, T Rio… - Journal of …, 2014 - Wiley Online Library
ICD Interventions and Mortality Background Patients with severe structural heart disease
have increased mortality after implantable cardioverter‐defibrillator (ICD) shocks. Whether …
have increased mortality after implantable cardioverter‐defibrillator (ICD) shocks. Whether …
The antitachycardia pacing ICD: impact on patient selection and outcome
JN Gross, RD Sackstein, SL Song… - Pacing and Clinical …, 1993 - Wiley Online Library
Implantable cardioverter defibrillators (ICD) currently undergoing clinical investigation
incorporate antitachycardia pacing capabilities, but little is known about their effect on …
incorporate antitachycardia pacing capabilities, but little is known about their effect on …
Effect of elevated heart rate preceding the onset of ventricular tachycardia on antitachycardia pacing effectiveness in patients with implantable cardioverter …
C Kouakam, B Lauwerier, D Klug, M Jarwe… - The American journal of …, 2003 - Elsevier
The incorporation of antitachycardia pacing (ATP) into implantable cardioverter defibrillators
(ICDs) has provided a better tolerated alternative to shocks. ATP has been shown to be …
(ICDs) has provided a better tolerated alternative to shocks. ATP has been shown to be …
Increased hospitalizations and overall healthcare utilization in patients receiving implantable cardioverter-defibrillator shocks compared with antitachycardia pacing
Objectives: The purpose of this study was to evaluate the effect of these therapies on
healthcare utilization in a large patient cohort. Background: Antitachycardia pacing (ATP) …
healthcare utilization in a large patient cohort. Background: Antitachycardia pacing (ATP) …